Akeso

If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of…

Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…

China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…

China’s cost and efficiency advantages in drug development have been recognised at the world’s largest cancer research conference in the…

Hong Kong’s stock market rally is expected to extend into the second half of the year, thanks to a surge…

Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…

Shares of Chinese cancer drug developer Akeso slumped on Monday despite the company receiving a second marketing approval from the…

China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…